Glo1 inducer supplement development

Glocentrica Ltd has ownership of patents issued in USA and Europe of Glo1 inducer (trans-resveratrol and hesperetin and related combinations). Glo1 inducer supports improved glycemic health in overweight and obese subjects – validated in clinical trial, and healthy aging. We welcome inquiries for licensing of Glo1 inducer technology.

Contact Glocentrica Ltd

Consulting opportunities on AGEomics

Directors of Glocentrica Ltd have over 20 years of experience and pioneering expertise in establishing the AGEomics platform on LC-MS/MS platforms. This includes standard operating procedures, access to analytical standards, analytical performance and expected values and reference intervals for many applications. We are open to technology transfer through consultancy. We do not offer an analytical service at this time. Please contact us to see how we can help.

Contact Glocentrica Ltd